All News

I must admit when people call us cancer survivors "strong," it's a double-edged sword.

For patients with lymphoma or multiple myeloma, speaking up about symptoms of cytokine release syndrome can be lifesaving.

The combination of bispecific antibody CTX-009 and chemotherapy received Fast Track Designation for advanced, previously treated biliary tract cancers.

After reading a book about how Imbruvica was revolutionized for SLL and CLL, I now have a greater appreciation for the drugs I receive.

From “The Young and the Restless” actress dying of cancer to “Star Trek” actress 20 years pancreatic cancer-free, here’s what’s happening in the cancer space this week.

Patients with laryngeal cancer who stopped smoking before receiving treatment had better survival outcomes, compared with patients who actively smoke.

During chemo shortages, nurses have helped many patients receive enough treatment, measuring them down to the “minutiae of the milligrams.”

Receiving early transfusions and treatment to reduce transfusion dependency significantly improves survival and quality of life in low-risk MDS.

The day I found out I had cancer, my wife and I thought I would just be going in for a scan.

During this in-person event, over 500 attendees celebrated the remarkable efforts made by oncology nurses in the care of patients with cancer.

With Carvykti now approved for pretreated myeloma, there are conversations that patients should have with their providers before treatment, a nurse said.

Patients with heavily pretreated myeloma tended to have “really amazing results” with the CAR-T cell therapy, Carvykti.

At first, I wanted to avoid receiving chemotherapy at all costs, but I realized taking it would be the beginning of staying cancer-free.

Even though I lost my hair from cancer treatment, I didn't let that stop me from styling my hair with attitude.

Treatment with Enhertu “is an unprecedented approval” for patients with HER2-positive solid tumors who did not have many options, an expert told CURE®.

Tecentriq plus Cabometyx conferred no overall survival benefit when compared with chemotherapy, a study showed.

The FDA has granted accelerated approval to Ojemda for patients 6 months and older with relapsed or refractory pediatric low-grade glioma with a BRAF fusion or rearrangement, or BRAF V600 mutation.

While strolling through the woods, my eyes landed on a woodpecker, whose actions sparked a cancer analogy in my mind.

Lutathera was approved for patients 12 or older with SSTR-positive gastroenteropancreatic neuroendocrine tumors, the FDA announced.

The investigational drug ziftomenib is currently being evaluated for patients with relapsed/refractory NPM1-mutant acute myeloid leukemia.

When my wife was diagnosed with stage 3B melanoma, we decided to openly speak about our fears.

A treatment combination of Anktiva and Bacillus Calmette-Guérin was approved by the FDA for certain patients with non-muscle-invasive bladder cancer.

A cognitive behavioral therapy for insomnia may help cancer survivors, along with ways to manage insomnia via sleep pressure, an expert told CURE®.

Patient/provider trust, education and lifestyle choices are crucial as Black men face higher incidence and mortality in prostate cancer, experts said.

What it’s like having a “second birthday” after receiving a bone marrow transplant for my AML.

Many cancer survivors experience fear of recurrence, even years into survivorship, so here are ways to help manage and face this fear.

Any one of us stricken by cancer remembers our own breaking news.

"Moments feel better when they are stolen," wrote a cancer survivor.